Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Jun 29, 2011
BioWorld interviews Keith A. Katkin, President and Chief Executive Officer of AVANIR Pharmaceuticals at the 2011 BIO International Convention on June 27, 2010 in Washington, DC. Katkin discusses the FDA approval of AVANIR's recent drug, NUEDEXTA as well as its at-the-marketing offering.